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INTRODUCTION
Homeopathy is “a therapeutic method of using prepa-
rations of substances whose effects when adminis-
tered to healthy subjects correspond to the
manifestation of the disorder in the individual pa-
tient” 1. The discipline was developed by Samuel
Hahnemann (1755–1843) about 200 years ago.
Hahnemann postulated that
• if a remedy causes a symptom in a healthy vol-
unteer, then it can be used to treat that symptom
in a patient (the “like cures like” principle).
• if a remedy is potentized (that is, diluted and
sucussed), it becomes more rather than less ef-
fective (the “memory of water” theory).
• all diseases originate from the “itch” (psora),
gonorrhea (sycosis), or syphilis (lues).
The third of these assumptions is now all but
forgotten (I suspect that homeopaths feel embar-
rassed by its overt incorrectness), but despite the
fact that the two other axioms also fly in the face of
science, they still form the basis of homeopathy
today.
Initially Hahnemann was remarkably successful,
and homeopathy conquered much of the world 2.
With hindsight, this early popularity probably ac-
crued because, unlike many other therapies of the
time, homeopathy was not outright harmful. With
the eventual emergence of conventional treatments
that generated more good than harm, homeopathy’s
popularity faded.
OBSERVATIONAL DATA
Today homeopathy is back with a vengeance.
Why? Nobody really knows. The reasons are prob-
ably complex 3. One contributing factor seems to
be that observational studies regularly show that
patients receiving homeopathic treatments expe-
rience benefit 4,5. Others insist that any treatment
that has been around for 200 years has “stood the
test of time.”
Experience, the “test of time,” and observational
studies all have one thing in common: the lack of a
control. To be able to draw conclusions about cause
and effect, a positive or negative control is needed.
Observational data are, by definition, uncontrolled
and unreliable. Causal inferences are therefore not
appropriate.
Of course, medicine has a long tradition of disre-
garding this rather obvious fact 6. Whenever doctors
administer a treatment to a patient outside of a clini-
cal trial (that is, in an uncontrolled fashion), they are
likely to attribute the ensuing outcome to the specific
effects of their intervention. In other words, practi-
tioners regularly make causal inferences on less than
solid grounds.
It would be constructive to create conceptual
clarity about what really is going on in such a situ-
ation. Figure 1 schematically depicts the case of a
patient (or a group of patients) receiving homeopa-
thy. Over time, symptoms improve, and a therapeu-
tic effect is therefore perceived. The assumption of
homeopaths is, therefore, that this “perceived thera-
peutic effect” is attributable to the specific effects
of their intervention.
In reality, the “perceived therapeutic effect” can
be caused by a multitude of effects 7. Figure 2 shows
schematically the range of factors that could be in-
volved. It is easy to see that, even if the specific thera-
peutic effect were to be negative (that is, a
homeopathic treatment is harmful), the total perceived
therapeutic effect could still be positive. It follows
that ineffective (and even harmful) interventions can
be falsely associated with overall improvement.
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FIGURE 1 Schematic analysis of a typical treatment situation. PTE =
perceived therapeutic effect.
RIGOROUSLY CONTROLLED STUDIES
To minimize the effects of confounding and bias, only
one choice is available: to conduct rigorously designed
randomized clinical trials (RCTs). Some homeopaths in-
sist that such studies cannot be done or are meaningless
in homeopathy. The same homeopaths usually cheer
whenever a RCT emerges which suggests that homeopa-
thy is efficacious. The fact that such trials exist clearly
demonstrates that RCTs of homeopathy are possible 8.
In the area of cancer, only very few RCTs of ho-
meopathy have been published—just five, in fact 9.
Kulkarni 10 conducted a RCT to test the effective-
ness of homeopathy on the severity of radiotherapy-
related side effects. Patients with different types of
cancer (n = 82) were randomized into three parallel
arms receiving either placebo, cobaltum C30, or caus-
ticum C30 (the “C” means centesimal potency). Pa-
tients were evaluated weekly using an 18-point
radiation reaction profile, and the average grading
was calculated at the end of the study. Compared with
placebo, the reaction profile was lower in both ex-
perimental groups.
Oberbaum 11 tested the effectiveness of Traumeel S
(TRS, New York, NY, U.S.A.) for chemotherapy-in-
duced stomatitis after allogeneic or autologous stem-
cell transplantation. Patients (n = 30) were randomised
to two groups: the Traumeel S oral rinse or a placebo
rinse. Traumeel S contains arnica 2X, calendula 2X,
millefolium 3X, chamomilla 3X, symphytum 6X,
belladonna 2X ana 0.1 mL, aconitum 2X 0.06 mL,
bellis perennis 2X 0.05 mL, hypericum 2X 0.03 mL,
echinacea angustifolia 2X, echinacea purpurea 2X ana
0.025 mL, hamamelis 1X 0.01 mL, mercurius sol. 6X
0.05 g, and hepar sulfuris 6X 0.1 g (the “X” means
decimal potency). Significant differences favouring the
Traumeel S group were observed in terms of reduc-
tion in the severity or duration (or both) of stomatitis
and in time to worsening of symptoms. Patients in that
group showed a reduction in oral pain and discomfort,
in dryness of mouth and tongue, in difficulty of swal-
lowing, and in dysphagia.
Balzarini 12 tested the effectiveness of homeo-
pathic treatment for skin reactions during radiotherapy
treatment for breast cancer. Patients (n = 61) were ran-
domized into a group receiving three granules of bel-
ladonna 7CH twice daily and X-ray 15CH once daily
(the “CH” means centesimal Hahnemannian potency)
or a group receiving placebo. Patients treated with
homeopathy noted less hyperpigmentation and a de-
crease in skin temperature, but these differences were
no longer significant by the end of the 10-week fol-
low-up. Total severity scores favoured homeopathy,
but statistical significance for the difference was no-
ticed only during recovery.
Jacobs and colleagues 13 evaluated homeopathy
for menopausal symptoms in 83 breast cancer survi-
vors. Patients who suffered from an average of 3 hot
flushes daily for a month before the trial were ran-
domized into three groups: a placebo combination and
a verum single remedy; a verum combination medi-
cine and a verum single remedy; and two placebo com-
binations. Single remedies consisted of 35 different
homeopathic medications, mainly sepia, calcarea
carbonica, sulphur, lachesis, and kali carbonicum
(mostly high potencies). The combination remedy was
“Hyland’s menopause,” which contains amyl nitrate,
sanguinaria canadensis, and lachesis. No significant
differences were found between the three groups in
terms of symptom score over a 1-year period. A sig-
nificant improvement in general health score was ob-
served in both homeopathy groups as compared with
the placebo group. A significant increase in headache
was observed in the combination homeopathy group.
FIGURE 2 Schematic differentiation of factors contributing to the
perceived therapeutic effect (PTE). (A) Natural course of the disease;
(B) concomitant treatments, for example, self-administered over-
the-counter drugs that patients forget to tell their doctors about;
(C) regression toward the mean; (D) Hawthorn effect; (E) therapist–
patient interaction; (F) social desirability, that is, patients saying
that they are improved to please their doctor. The specific therapeutic
effect (STE) is, for example, the pharmacologic action of a drug. A
negative STE (dashed line) reduces the size of the PTE (dashed line),
but does not necessarily abolish it totally.HOMEOPATHY FOR CANCER?
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Thompson et al. 14 compared homeopathy with
placebo in 53 breast cancer survivors with estrogen
withdrawal symptoms. Patients randomized to ho-
meopathy were individually prescribed 71 different
remedies, most commonly sulphur, sepia, carcinosin,
natrum muriaticum, belladonna, and arnica (mostly
high potencies). No significant differences between
the experimental and the placebo group were noted.
COMMENT
Homeopathy is again popular—also with cancer pa-
tients. Observational data suggesting effectiveness
have to be interpreted with great caution. Random-
ized controlled trials are scarce, and those currently
available are burdened with significant methodologic
limitations 9. All of the existing RCTs are in the realm
of cancer palliation and supportive care. Independent
replication of these data are not currently available.
Few experts would argue that low-potency ho-
meopathic remedies (preparations that contain phar-
macologically active molecules) may generate clinical
effects. The dispute centres mainly on the issue of
whether high potency remedies (preparations diluted
beyond the Avogadro number) can be effective. Po-
tencies (dilutions) of botanic substances beyond 7C
(meaning 7 dilutions, each 1:100) do not contain a
sufficiently significant number of molecules of the
original material to be pharmacologically active 1.
Considering the biologic implausibility of high-
potency homeopathy, my conclusions have to be con-
servative. There is no evidence at all that homeopathic
remedies can change the natural history of any can-
cer. The few RCTs of homeopathy are in the realm of
cancer palliation and supportive care and have not
generated convincing evidence of a beneficial effect.
For indications other than cancer, the evidence from
rigorous RCTs is also not convincing 15. As a result,
there is no reason to believe that homeopathic medi-
cines have anything to offer to patients suffering from
cancer or other conditions apart from non-specific
effects. However, to generate the placebo effect, we
do not necessarily need placebos.
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